Dong, Di, Ozdemir, Semra, Bee, Yong Mong, Toh, Sue-Anne, Bilger, Marcel, Finkelstein, Eric. 2016. Measuring High-Risk Patients’ Preferences for Pharmacogenetic Testing to Reduce Severe Adverse Drug Reaction: A Discrete Choice Experiment. Value in Health. 19 (6), 767-775.

RIS

@ARTICLE{Dong2016,
title = {Measuring High-Risk Patients’ Preferences for Pharmacogenetic Testing to Reduce Severe Adverse Drug Reaction: A Discrete Choice Experiment},
author = {Di Dong and Semra Ozdemir and Yong Mong Bee and Sue-Anne Toh and Marcel Bilger and Eric Finkelstein},
year = {2016},
doi = {http://dx.doi.org/10.1016/j.jval.2016.03.1837},
volume = {19},
number = {6},
language = {EN},
pages = {767-775},
journal = {Value in Health},
abstract = {Objectives To investigate patient preferences and willingness to pay (WTP) for a genetic test that can reduce the risk of life-threatening adverse drug reactions (ADRs). We hypothesize that test features (risk of developing the adverse reaction with and without testing, test cost, and treatment cost) and the choice context (physician recommendation and the most common choice made by peer patients) will influence choices. Methods A discrete choice experiment was conducted in which 189 patients at high risk for gout were asked to choose between treatment options that varied along key attributes. A latent class logit model was used to analyze the choice data and test the hypotheses.},
}